Concepedia

Publication | Open Access

Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab

21

Citations

20

References

2022

Year

Abstract

Patients partially treated with teprotumumab achieve significant reduction in proptosis, CAS, and extraocular muscle restriction and maintain these improvements through the period of interruption.

References

YearCitations

Page 1